- Home
- SAGE vs GES Comparison
SAGE vs GES Comparison
Compare SAGE & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- GES
- Stock Information
- Founded
- SAGE 2010
- GES 1981
- Country
- SAGE United States
- GES Switzerland
- Employees
- SAGE N/A
- GES N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- SAGE Health Care
- GES Consumer Discretionary
- Exchange
- SAGE Nasdaq
- GES Nasdaq
- Market Cap
- SAGE 571.1M
- GES 628.9M
- IPO Year
- SAGE 2014
- GES 1996
- Fundamental
- Price
- SAGE $9.12
- GES $12.70
- Analyst Decision
- SAGE Hold
- GES Buy
- Analyst Count
- SAGE 18
- GES 4
- Target Price
- SAGE $9.89
- GES $17.75
- AVG Volume (30 Days)
- SAGE 1.8M
- GES 687.6K
- Earning Date
- SAGE 07-30-2025
- GES 08-27-2025
- Dividend Yield
- SAGE N/A
- GES 9.14%
- EPS Growth
- SAGE N/A
- GES N/A
- EPS
- SAGE N/A
- GES 0.10
- Revenue
- SAGE $47,404,000.00
- GES $3,051,131,000.00
- Revenue This Year
- SAGE $101.71
- GES $7.34
- Revenue Next Year
- SAGE $42.30
- GES $3.20
- P/E Ratio
- SAGE N/A
- GES $135.81
- Revenue Growth
- SAGE N/A
- GES 9.02
- 52 Week Low
- SAGE $4.62
- GES $8.48
- 52 Week High
- SAGE $13.47
- GES $24.64
- Technical
- Relative Strength Index (RSI)
- SAGE 66.62
- GES 53.42
- Support Level
- SAGE $9.10
- GES $11.99
- Resistance Level
- SAGE $9.36
- GES $13.63
- Average True Range (ATR)
- SAGE 0.10
- GES 0.50
- MACD
- SAGE -0.09
- GES -0.05
- Stochastic Oscillator
- SAGE 29.69
- GES 43.29
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.